SG10201506978UA - Inhibitors Of Cognitive Decline - Google Patents
Inhibitors Of Cognitive DeclineInfo
- Publication number
- SG10201506978UA SG10201506978UA SG10201506978UA SG10201506978UA SG10201506978UA SG 10201506978U A SG10201506978U A SG 10201506978UA SG 10201506978U A SG10201506978U A SG 10201506978UA SG 10201506978U A SG10201506978U A SG 10201506978UA SG 10201506978U A SG10201506978U A SG 10201506978UA
- Authority
- SG
- Singapore
- Prior art keywords
- inhibitors
- cognitive decline
- cognitive
- decline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/25—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/05—Alcohols containing rings other than six-membered aromatic rings
- C07C33/14—Alcohols containing rings other than six-membered aromatic rings containing six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/28—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings
- C07C33/30—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings monocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
- C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/18—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23032609P | 2009-07-31 | 2009-07-31 | |
| US30868610P | 2010-02-26 | 2010-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201506978UA true SG10201506978UA (en) | 2015-10-29 |
Family
ID=43529740
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012006805A SG178191A1 (en) | 2009-07-31 | 2010-08-02 | Inhibitors of cognitive decline |
| SG10201506978UA SG10201506978UA (en) | 2009-07-31 | 2010-08-02 | Inhibitors Of Cognitive Decline |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012006805A SG178191A1 (en) | 2009-07-31 | 2010-08-02 | Inhibitors of cognitive decline |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9192585B2 (en) |
| EP (1) | EP2458983B1 (en) |
| JP (1) | JP2013501006A (en) |
| CN (1) | CN102595884B (en) |
| AU (2) | AU2010278711A1 (en) |
| BR (1) | BR112012002246A2 (en) |
| DK (1) | DK2458983T3 (en) |
| ES (1) | ES2547730T3 (en) |
| HK (1) | HK1171624A1 (en) |
| IL (1) | IL217833A0 (en) |
| RU (1) | RU2012107457A (en) |
| SG (2) | SG178191A1 (en) |
| WO (1) | WO2011014880A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010234518A1 (en) | 2009-04-09 | 2012-02-02 | Cognition Therapeutics, Inc. | Inhibitors of cognitive decline |
| WO2011014880A1 (en) * | 2009-07-31 | 2011-02-03 | Cognition Therapeutics, Inc. | Inhibitors of cognitive decline |
| WO2011106785A2 (en) * | 2010-02-26 | 2011-09-01 | Cognition Therapeutics, Inc. | Methods of identifying agents effective to treat cognitive decline and diseases associated therewith |
| US9499462B2 (en) | 2011-02-02 | 2016-11-22 | Cognition Therapeutics, Inc. | Isolated compounds from turmeric oil and methods of use |
| EP2690969B1 (en) * | 2011-03-29 | 2018-10-03 | Council of Scientific & Industrial Research | Process for the modification of curcuma aromatica essential oil |
| GB201111319D0 (en) * | 2011-07-04 | 2011-08-17 | Univ Leuven Kath | Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa |
| CN104053435A (en) * | 2011-08-25 | 2014-09-17 | 考格尼申治疗股份有限公司 | Compositions and methods for treating neurodegenerative disease |
| WO2013029060A2 (en) * | 2011-08-25 | 2013-02-28 | Cognition Therapeutics, Inc. | Compositions and methods for treating neurodegenerative disease |
| DK3498692T3 (en) | 2014-01-31 | 2022-05-16 | Cognition Therapeutics Inc | Isoindoline compositions and methods for treating neurodegenerative disease and macular degeneration |
| BR112019023851A2 (en) | 2017-05-15 | 2020-08-18 | Cognition Therapeutics, Inc. | compounds, their pharmaceutical compositions and methods for treating neurodegenerative diseases |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA732136B (en) | 1972-04-12 | 1974-03-27 | Lilly Co Eli | Dopamine derivatives |
| US4321386A (en) | 1981-01-28 | 1982-03-23 | Mead Johnson & Company | Quaternary piperidinium halides |
| DK171627B1 (en) | 1983-01-31 | 1997-03-03 | Lilly Co Eli | Use of beta-phenethanolamine and pharmaceutically acceptable salts thereof and animal feed pre-mix thereof |
| JPS62283922A (en) | 1986-05-30 | 1987-12-09 | Tsumura Juntendo Inc | Platelet coagulation inhibiting agent |
| US4697024A (en) | 1986-11-24 | 1987-09-29 | Merrell Dow Pharmaceuticals Inc. | Medroxalol intermediates |
| US4958029A (en) | 1987-01-13 | 1990-09-18 | Banyu Pharmaceutical Co., Ltd. | Process for the production of isoindoline derivatives, novel intermediates and process for their production |
| JPH01180822A (en) | 1988-01-12 | 1989-07-18 | Dainippon Pharmaceut Co Ltd | Anti-delayed type allergic agent |
| EP0507863A4 (en) | 1989-12-28 | 1993-07-07 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
| DE4000610A1 (en) | 1990-01-11 | 1991-07-18 | Knoll Ag | Optically active 1-aryl-3-amino-butane derivs. prodn. - by fractional crystallisation of salts with optically active acid, useful as pharmaceutical intermediates |
| JP2818958B2 (en) | 1990-02-23 | 1998-10-30 | 塩野義製薬株式会社 | 4- (4-Alkoxyphenyl) -2-butylamine derivative and method for producing the same |
| JPH045266A (en) | 1990-04-24 | 1992-01-09 | Toyo Pharma- Kk | Production of dopamine derivative |
| DE4123341A1 (en) * | 1991-07-15 | 1993-01-21 | Thomae Gmbh Dr K | PHENYL ALKYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
| DE4142366A1 (en) | 1991-07-15 | 1993-06-24 | Thomae Gmbh Dr K | New phenylalkyl derivs. - are angiotensin II antagonists used to treat hypertension, coronary insufficiency, angina, cns disorders etc. |
| US6011068A (en) | 1991-08-23 | 2000-01-04 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| AU702629B2 (en) | 1991-08-23 | 1999-02-25 | Nps Pharmaceuticals, Inc. | Calcium receptor-active arylalkyl amines |
| US6610493B1 (en) | 1993-06-17 | 2003-08-26 | Brigham And Women's Hospital | Screening compounds for the ability to alter the production of amyloid-β peptide |
| CA2115900A1 (en) | 1993-02-22 | 1994-08-23 | Gerald W. Becker | Pharmaceutical screens and antibodies |
| HU228150B1 (en) | 1994-10-21 | 2012-12-28 | Nps Pharma Inc | Calcium receptor-active compounds, medicaments comprising them, and the use of said medicaments |
| JP3522930B2 (en) * | 1995-12-06 | 2004-04-26 | 花王株式会社 | Antimicrobial agent and oral composition containing the same |
| WO1997030038A1 (en) | 1996-02-15 | 1997-08-21 | Mitsubishi Chemical Corporation | Diarylsultam derivatives |
| US6235731B1 (en) | 1996-04-24 | 2001-05-22 | Takeda Chemical Industries, Ltd. | Fused imidazopyridine derivatives as antihyperlipidemic agents |
| US6518315B1 (en) | 1997-10-21 | 2003-02-11 | The University Of Sydney | Medicinal uses of phenylaikanols and derivatives |
| IL138686A0 (en) | 1999-10-01 | 2001-10-31 | Pfizer Prod Inc | α- SULFONYLAMINO HYDROXAMIC ACID INHIBITORS OF MATRIX METALLOPROTEINASES FOR THE TREATMENT OF PERIPHERAL OR CENTRAL NERVOUS SYSTEM DISORDERS |
| AU2300001A (en) | 1999-10-22 | 2001-05-08 | Board Of Trustees Of The University Of Illinois, The | Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease |
| DE10027151A1 (en) | 2000-05-31 | 2001-12-06 | Bayer Ag | Herbicides based on substituted carboxamides |
| JP4312402B2 (en) | 2001-07-31 | 2009-08-12 | 有限会社大長企画 | Anti-depressant, anti-menopausal agent, anti-senile dementia agent, anti-Alzheimer agent |
| WO2003016274A2 (en) | 2001-08-21 | 2003-02-27 | Sepracor, Inc. | 2-substituted piperidines that are ligands for monoamine receptors and transporters |
| US6991814B2 (en) * | 2001-12-13 | 2006-01-31 | Council Of Scientific And Industrial Research | Herbal medicaments for the treatment of neurocerebrovascular disorders |
| EA007067B1 (en) * | 2001-12-14 | 2006-06-30 | Каунсил Оф Сайентифик Энд Индастриал Рисерч | Composition for treating of neurocerebrovascular disorders |
| JP2004002517A (en) | 2002-05-31 | 2004-01-08 | Dae Sil Kim | Composition of soap containing ginger ingredient and method for producing the same |
| DE10320560A1 (en) | 2003-05-07 | 2004-01-29 | Brosig, Stefan, Dr. | Prophylaxis or treatment of Alzheimer's disease and/or Parkinson's disease, by administration of ginger, specifically in food and/or as ginger extract |
| EP1644026A4 (en) | 2003-06-12 | 2007-10-24 | Ms Science Corp | Sigma ligands for neuronal regeneration and functional recovery |
| CN1925849A (en) | 2004-03-12 | 2007-03-07 | 埃吉斯药物工厂 | Pharmaceutical composition for inhibiting cognition hypofunction |
| JPWO2005115366A1 (en) * | 2004-05-31 | 2008-03-27 | 株式会社カネカ | Lifestyle-related disease prevention / amelioration agent containing turmeric essential oil component |
| AU2005253776B8 (en) | 2004-06-21 | 2012-02-02 | King's College London | Screening methods using c-Abl, Fyn and Syk in combination with tau protein |
| TW200613272A (en) | 2004-08-13 | 2006-05-01 | Astrazeneca Ab | Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| US20080153917A1 (en) | 2004-09-10 | 2008-06-26 | Ucb Pharma, S.A. | Sigma Receptor Ligands |
| US20060153772A1 (en) | 2004-12-15 | 2006-07-13 | Wyeth | Contextual fear conditioning for predicting immunotherapeutic efficacy |
| ES2340414T3 (en) | 2005-03-05 | 2010-06-02 | ABBOTT GMBH & CO. KG | METHOD OF SELECTION, PROCESS FOR PURIFICATION OF NON-DIFFUSIBLE A-BETA OLIGOMERS, SELECTIVE ANTIBODIES AGAINST SUCH NON-DIFFUSABLE A-BETA OLIGOMERS AND A PROCESS FOR THE MANUFACTURE OF SUCH ANTIBODIES. |
| US20070003641A1 (en) | 2005-06-15 | 2007-01-04 | Kim Darrick S H | Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease |
| EP1745778A3 (en) | 2005-07-20 | 2007-03-07 | Speedel Experimenta AG | Diaminoalcohols as therapeutic compounds |
| ITRM20060007A1 (en) | 2006-01-05 | 2007-07-06 | Univ Bari | SIGMA-2 RECEPTOR METHOD OF SCREENING OF SPECIFIC LIGANDS AND USE OF THE SAME IN DIAGNOSTIC OR THERAPEUTIC METHODS |
| JP2009530305A (en) * | 2006-03-17 | 2009-08-27 | ハーバルサイエンス シンガポール ピーティーイー． リミテッド | Extracts and methods containing turmeric species |
| WO2007112288A2 (en) | 2006-03-23 | 2007-10-04 | Mount Sinai School Of Medicine | Cardiovascular composition and use the same for the treatment of alzheimers disease |
| US7561775B2 (en) | 2006-08-22 | 2009-07-14 | Senko Advanced Components, Inc. | Fiber optic protective shutter |
| WO2008042755A2 (en) | 2006-09-29 | 2008-04-10 | Cognition Therapeutics, Inc. | Inhibitors of cognitive decline |
| US20100028333A1 (en) | 2006-12-15 | 2010-02-04 | Getty Krista L | Receptor for amyloid beta and uses thereof |
| CA2684920A1 (en) | 2007-05-15 | 2008-11-27 | Helicon Therapeutics, Inc. | Methods of treating cognitive disorders by inhibition of gpr12 |
| CN101121670A (en) | 2007-09-11 | 2008-02-13 | 上海紫源制药有限公司 | Method for preparing 3,4-dimethoxy-N-[3-(4-methoxyphenyl)-1-methyl-n-propyl]-beta-phenylethylamine hydrochloride |
| DK2206707T3 (en) | 2007-10-24 | 2014-08-11 | Astellas Pharma Inc | AZOLCARBOXAMIDE COMPOUND OR SALT THEREOF |
| WO2009059214A1 (en) | 2007-11-02 | 2009-05-07 | The Regents Of The University Of California | Abeta-binding small molecules |
| EP2138104A1 (en) | 2008-06-25 | 2009-12-30 | Vibra Tech AB | Core biopsy arrangement |
| KR101515822B1 (en) | 2008-11-29 | 2015-04-29 | 더 타일랜드 리서치 펀드 | Virus and target cell interaction inhibition |
| WO2010088450A2 (en) | 2009-01-30 | 2010-08-05 | Celladon Corporation | Methods for treating diseases associated with the modulation of serca |
| WO2010107825A2 (en) | 2009-03-16 | 2010-09-23 | Pangu Biopharma Limited | Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| AU2010234518A1 (en) | 2009-04-09 | 2012-02-02 | Cognition Therapeutics, Inc. | Inhibitors of cognitive decline |
| WO2011014880A1 (en) * | 2009-07-31 | 2011-02-03 | Cognition Therapeutics, Inc. | Inhibitors of cognitive decline |
| WO2011106785A2 (en) | 2010-02-26 | 2011-09-01 | Cognition Therapeutics, Inc. | Methods of identifying agents effective to treat cognitive decline and diseases associated therewith |
| CN104053435A (en) | 2011-08-25 | 2014-09-17 | 考格尼申治疗股份有限公司 | Compositions and methods for treating neurodegenerative disease |
-
2010
- 2010-08-02 WO PCT/US2010/044136 patent/WO2011014880A1/en active Application Filing
- 2010-08-02 JP JP2012523127A patent/JP2013501006A/en active Pending
- 2010-08-02 AU AU2010278711A patent/AU2010278711A1/en not_active Abandoned
- 2010-08-02 RU RU2012107457/04A patent/RU2012107457A/en not_active Application Discontinuation
- 2010-08-02 EP EP10805177.2A patent/EP2458983B1/en active Active
- 2010-08-02 SG SG2012006805A patent/SG178191A1/en unknown
- 2010-08-02 CN CN201080043697.0A patent/CN102595884B/en not_active Expired - Fee Related
- 2010-08-02 US US13/388,128 patent/US9192585B2/en active Active
- 2010-08-02 ES ES10805177.2T patent/ES2547730T3/en active Active
- 2010-08-02 BR BR112012002246A patent/BR112012002246A2/en not_active IP Right Cessation
- 2010-08-02 DK DK10805177.2T patent/DK2458983T3/en active
- 2010-08-02 SG SG10201506978UA patent/SG10201506978UA/en unknown
-
2012
- 2012-01-30 IL IL217833A patent/IL217833A0/en unknown
- 2012-12-05 HK HK12112555.8A patent/HK1171624A1/en not_active IP Right Cessation
-
2015
- 2015-10-12 AU AU2015242947A patent/AU2015242947B2/en not_active Ceased
- 2015-10-16 US US14/885,768 patent/US9815770B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2012107457A (en) | 2013-09-10 |
| SG178191A1 (en) | 2012-03-29 |
| US9815770B2 (en) | 2017-11-14 |
| JP2013501006A (en) | 2013-01-10 |
| DK2458983T3 (en) | 2015-10-05 |
| IL217833A0 (en) | 2012-03-29 |
| HK1171624A1 (en) | 2013-04-05 |
| US20120129945A1 (en) | 2012-05-24 |
| WO2011014880A1 (en) | 2011-02-03 |
| CN102595884A (en) | 2012-07-18 |
| EP2458983A4 (en) | 2012-12-19 |
| ES2547730T3 (en) | 2015-10-08 |
| CN102595884B (en) | 2014-12-03 |
| BR112012002246A2 (en) | 2019-09-24 |
| AU2015242947B2 (en) | 2017-09-28 |
| AU2010278711A1 (en) | 2012-02-23 |
| AU2015242947A1 (en) | 2015-10-29 |
| EP2458983A1 (en) | 2012-06-06 |
| EP2458983B1 (en) | 2015-07-08 |
| US20160137588A1 (en) | 2016-05-19 |
| US9192585B2 (en) | 2015-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201700326B (en) | Inhibitors of beta-secretase | |
| EP2391623A4 (en) | Inhibitors of akt activity | |
| EP2440054A4 (en) | Pyridil-triazine inhibitors of hedgehog signaling | |
| ZA201206424B (en) | Inhibitors of semicarabazide-sensitive amine oxidase | |
| EP2413932A4 (en) | Inhibitors of akt activity | |
| PL2521746T3 (en) | Inhibition of amine oxidation | |
| IL218018A0 (en) | Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions | |
| EP2406250A4 (en) | Inhibitors of akt activity | |
| HK1171624A1 (en) | Inhibitors of cognitive decline | |
| HK1167323A1 (en) | Inhibitors of cognitive decline | |
| ZA201206456B (en) | Uses of dgati inhibitors | |
| EP2405756A4 (en) | Inhibitors of akt activity | |
| SI2506840T1 (en) | Uses of hypoxia-inducible factor inhibitors | |
| HK1167654A1 (en) | Dihydropyrrolonaphtyridinone compounds as inhibitors of jak jak dihydropyrrolonaphtyridinone | |
| HK1171013A1 (en) | Inhibitors of akt activity akt | |
| PL2493496T3 (en) | Use of gstp1 | |
| IL217756A0 (en) | Inhibitors of jnk | |
| GB0908609D0 (en) | New use of isoQC inhibitors | |
| LU91725B1 (en) | Novel uses of V-ATPASE inhibitors | |
| EP2513059A4 (en) | Inhibitors of akt activity | |
| GB0903651D0 (en) | Inhibitors of glyoxalase | |
| GB0905098D0 (en) | Use of biomarkers | |
| GB0905280D0 (en) | Novel uses of VEGFxxxb | |
| IL220242A0 (en) | Methods of improving cognitive functions | |
| GB0911084D0 (en) | New use of statins |